67046-1531 : Amantadine 100 mg Oral Tablet


NDC67046-1531
Labeler: Coupler LLC
Product Type: Human Prescription Drug
Drug Name:  Amantadine
Dosage Form: Oral Tablet
Application #: ANDA214284
Rev. Date: 


NDC Package Codes:

  • 67046-1531-3: 30 TABLET IN 1 BLISTER PACK (67046‑1531‑3)

Active Ingredients:

  • Amantadine Hydrochloride

Dosage Strength:

  • 100 mg

Pharmaceutical Classes:

  • Influenza A M2 Protein Inhibitor [EPC]
  • M2 Protein Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0116-4010 Amantadine 50 mg/5ml Oral Solution by Xttrium Laboratories, Inc
  • 46708-246 Amantadine 100 mg Oral Capsule by Alembic Pharmaceuticals Limited
  • 46708-586 Amantadine 100 mg Oral Tablet by Alembic Pharmaceuticals Limited
  • 60687-422 Amantadine 100 mg Oral Capsule by American Health Packaging
  • 62332-246 Amantadine 100 mg Oral Capsule by Alembic Pharmaceuticals Inc.
  • 62332-586 Amantadine 100 mg Oral Tablet by Alembic Pharmaceuticals Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 67046-1531 QR Code

< Prev: 67046-1530Next: 67046-1532 >

Related Discussions:

Amantadine for energy
My Neurologist gave me Amantadine for Fibfromyalgia and Chronic Fatigue Syndrome, he said this would give me energy, but... 2 replies
Amantadine oral for Parkinsons
Given to much of the drug. Added an extra pill to his night time pills. Have trouble with seeing things ## Hello, Ben! H... 1 reply
Amantadine uses
Can you take this medicine to help give you energy? ## Hello, Luvbug! How are you? Yes, Amantadine is sometimes used off... 1 reply
amantadine(?)
has the code of c=122 on it. what does that mean??...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.